Stock Market Today: Dow, S&P 500 Surge Late, Set New Highs

Investors ignored weak February spending data and lifted the Dow and S&P 500 from decent gains to record territory with a Friday afternoon push.

A pole vaulter clears a high bar
(Image credit: Getty Images)

Wall Street looked like it was going to close the week in tame fashion, but buyers rushed in during the final hour to send all the major indices to strong gains.

The Commerce Department reported Friday that personal income declined by 7.1% in February, slightly better than the 7.3% drop economists were expecting in a month with storm disruptions, fewer working days and no stimulus checks.

However, consumer spending declined 1% last month, undershooting estimates of a 0.7% decline – but that should snap back in March thanks to outgoing stimulus checks.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

The Dow Jones Industrial Average (+1.4% to 33,072) and the S&P 500 (+1.7% to 3,974) were both en route to modest gains, and then a final-hour rally propelled them to new all-time highs. The industrial average was led by Cisco Systems (CSCO, +4.1%), Nike (NKE, +3.4%) and Intel (INTC, +4.6%).

The latter joined in a broad semiconductor rally that included Qualcomm (QCOM, +4.5%), Broadcom (AVGO, +4.4%) and Texas Instruments (TXN, +5.4%) to help the Nasdaq Composite (+1.2% to 13,138) flip from red to green in the late afternoon.

Sign up for Kiplinger's FREE Investing Weekly e-letter for stock, ETF and mutual fund recommendations, and other investing advice.

Other action in the stock market today:

  • The small-cap Russell 2000 rocketed 1.3% higher to 2,211.
  • Tesla (TSLA) declined 3.4% despite CEO Elon Musk's best efforts to prop it up – Musk tweeted there's "a >0% chance Tesla could be the biggest company," then followed it up with another tweet saying "Probably within a few months" that he quickly deleted.
  • Comcast (CMCSA, -2.0%) dropped after DAZN Group, known as "the Netflix of sport," outbid Comcast's Sky division for a major Italian soccer contract.
  • U.S. crude oil futures sprang back again, jumping 4.8% to settle at $61.35 per barrel.
  • Gold futures edged 0.4% higher to $1,732.30 per ounce.
  • Bitcoin prices joined the rally as well, climbing 3.2% to $53,832. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.)

stock chart for 032621

(Image credit: YCharts)

One Bright Outlook for the Next Few Months

More encouragingly, the first-quarter earnings season will soon be upon us, and corporate America is expecting it to be a doozy. John Butters, senior earnings analyst at FactSet, notes that 60 S&P 500 companies have issued positive earnings per share (EPS) guidance for the first quarter.

"If 60 is the final number of S&P 500 companies issuing positive EPS guidance for the quarter, it will mark the highest number of S&P 500 companies issuing positive EPS guidance for a quarter since FactSet began tracking this metric in 2006," he says. "The current record is 57, which occurred in the previous quarter (Q4 2020)."

It could be an especially good quarter for tech stocks, as the sector leads the way with 29 companies issuing positive guidance.

Analysts are bullish on the sector, too, rating 61% of the S&P 500's tech stocks as Buys – but they feel equally as strong about energy, which has surged over the past few months, and healthcare.

While not as flashy as tech and not as recently en vogue as energy, healthcare is a favorite among buy-and-hold investors given the sector's ability to provide performance in bull and bear markets. Particularly attractive on this front are the sector's Big Pharma names, which provide not just stability, but typically well-above-average yields.

Read on as we explore seven large pharmaceutical stocks that are mostly just churning along with little fanfare, but that income investors can always appreciate.

Kyle Woodley

Kyle Woodley is the Editor-in-Chief of WealthUp, a site dedicated to improving the personal finances and financial literacy of people of all ages. He also writes the weekly The Weekend Tea newsletter, which covers both news and analysis about spending, saving, investing, the economy and more.

Kyle was previously the Senior Investing Editor for, and the Managing Editor for before that. His work has appeared in several outlets, including Yahoo! Finance, MSN Money, Barchart, The Globe & Mail and the Nasdaq. He also has appeared as a guest on Fox Business Network and Money Radio, among other shows and podcasts, and he has been quoted in several outlets, including MarketWatch, Vice and Univision. He is a proud graduate of The Ohio State University, where he earned a BA in journalism. 

You can check out his thoughts on the markets (and more) at @KyleWoodley.